Literature DB >> 34387755

Validity and reliability of the Turkish version of "the Dyspnea-ALS-Scale (DALS-15)".

Esma Nur Kolbaşı1,2, Ece Açıkbaş1, Gamze Polen Akşimşek1, Gökşen Kuran Aslan3,4, Esen Kıyan5.   

Abstract

AIM: The aim of this study was to investigate the validity and reliability of the Turkish version of The Dyspnea-ALS-Scale (DALS-15).
METHODS: Forward translation, back translation, and cross-cultural adaptation were used to ensure the equivalency of translated version of the scale. Then, patients with amyotrophic lateral sclerosis (ALS) who have dyspnea or orthopnea that develops with effort or at rest were evaluated using DALS-15 via online surveys. The respiratory subscale of ALS Functional Rating Scale-Revised (ALSFRS-R) and Modified Borg Dyspnea Scale (MBDS) was used to investigate the construct validity of the Turkish DALS-15. Reliability was assessed with Cronbach's α and inter-item correlation matrix (internal consistency).
RESULTS: We have included 52 ALS patients in the study. Findings showed that Turkish version of DALS-15 was highly correlated with respiratory subscale of ALSFRS-R (r =  - 0.668; p =  < 0.0001) and MBDS (for upright position: r = 0.728; p =  < 0.0001 and for supine: r = 0.78; p =  < 0.0001). The scale did not show any ceiling or floor effect. Also, DALS-15 had a high level of Cronbach's α (0.95) and internal consistency (ICC: 0.949; 95%CI: 0.92-0.96). Test-re-test reliability of the questionnaire was (ICC: 0.909; 95% CI: 0.81-0.95). The standard error of measurement value was 2.76, whereas the minimal detectable change score was 7.66 points for the translated version of the scale.
CONCLUSIONS: The Turkish version of DALS-15 possesses strong psychometric properties with excellent validity and reliability. It is shown to be useful for online self-assessment, outside of the clinical settings, especially in hard times such as a pandemic.
© 2021. Fondazione Società Italiana di Neurologia.

Entities:  

Keywords:  Amyotrophic Lateral sclerosis; Dyspnea; Reproducibility of results; Validation study

Mesh:

Year:  2021        PMID: 34387755     DOI: 10.1007/s10072-021-05516-4

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  13 in total

1.  The Severe Respiratory Insufficiency (SRI) Questionnaire: a specific measure of health-related quality of life in patients receiving home mechanical ventilation.

Authors:  Wolfram Windisch; Klaus Freidel; Bernd Schucher; Hansjörg Baumann; Matthias Wiebel; Heinrich Matthys; Franz Petermann
Journal:  J Clin Epidemiol       Date:  2003-08       Impact factor: 6.437

2.  Dyspnea in amyotrophic lateral sclerosis: The Dyspnea-ALS-Scale (DALS-15) essentially contributes to the diagnosis of respiratory impairment.

Authors:  S Vogt; S Schreiber; K Kollewe; S Körner; H-J Heinze; R Dengler; S Petri; S Vielhaber
Journal:  Respir Med       Date:  2019-06-19       Impact factor: 3.415

3.  Diaphragmatic dysfunction at the first visit to a chest diseases outpatient clinic in 500 patients with amyotrophic lateral sclerosis.

Authors:  Aylin Pihtili; Zuleyha Bingol; Hacer Durmus; Yesim Parman; Esen Kiyan
Journal:  Muscle Nerve       Date:  2021-02-25       Impact factor: 3.217

4.  Adaptation to Turkish and Reliability Study of the Revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-R).

Authors:  Filiz Koç; Mehmet Balal; Turgay Demir; Z Nazan Alparslan; Yakup Sarica
Journal:  Noro Psikiyatr Ars       Date:  2016-09-01       Impact factor: 1.339

5.  Respiratory systems abnormalities and clinical milestones for patients with amyotrophic lateral sclerosis with emphasis upon survival.

Authors:  Robert L Vender; David Mauger; Susan Walsh; Shoaib Alam; Zachary Simmons
Journal:  Amyotroph Lateral Scler       Date:  2007-02

6.  Online assessment of ALS functional rating scale compares well to in-clinic evaluation: a prospective trial.

Authors:  André Maier; Teresa Holm; Paul Wicks; Laura Steinfurth; Peter Linke; Christoph Münch; Robert Meyer; Thomas Meyer
Journal:  Amyotroph Lateral Scler       Date:  2012-02

7.  Development and validation of the Cancer Dyspnoea Scale: a multidimensional, brief, self-rating scale.

Authors:  K Tanaka; T Akechi; T Okuyama; Y Nishiwaki; Y Uchitomi
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

8.  Assessment of pulmonary function in amyotrophic lateral sclerosis: when can polygraphy help evaluate the need for non-invasive ventilation?

Authors:  Tino Prell; Thomas M Ringer; Kara Wullenkord; Philipp Garrison; Anne Gunkel; Beatrice Stubendorff; Otto W Witte; Julian Grosskreutz
Journal:  J Neurol Neurosurg Psychiatry       Date:  2016-03-24       Impact factor: 10.154

9.  The Dyspnea-ALS-Scale (DALS-15) optimizes individual treatment in patients with amyotrophic lateral sclerosis (ALS) suffering from dyspnea.

Authors:  Susanne Vogt; Stefanie Schreiber; Hans-Jochen Heinze; Reinhard Dengler; Susanne Petri; Stefan Vielhaber
Journal:  Health Qual Life Outcomes       Date:  2019-06-03       Impact factor: 3.186

10.  Association of lead exposure with survival in amyotrophic lateral sclerosis.

Authors:  Freya Kamel; David M Umbach; Lillian Stallone; Marie Richards; Howard Hu; Dale P Sandler
Journal:  Environ Health Perspect       Date:  2008-07       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.